GSTM1 [corrected] deletion modifies the levels of polycyclic aromatic hydrocarbon-DNA adducts in human sperm

Area of Science:

• Environmental Health
• Toxicology
• Genetics

Background:

• DNA adducts in tissues are key biomarkers for carcinogen-induced organ damage.
• Genetic polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism genes can alter PAH-DNA adduct levels.
• Investigating these polymorphisms in sperm DNA is crucial for understanding male reproductive health risks.

Purpose of the Study:

• To examine the impact of the GSTM1 (glutathione S-transferase M1) gene polymorphism on DNA adduct formation in human sperm.
• To assess the combined effects of GSTM1 genotype and occupational PAH exposure on sperm DNA adduct levels.

Main Methods:

• Genotyping for the GSTM1 deletion polymorphism in a cohort of men.
• Quantification of PAH-DNA adducts in sperm using immunofluorescence assays.
• Statistical analysis to compare adduct levels based on GSTM1 genotype and occupational exposure.

Main Results:

• Sperm from men with the homozygous GSTM1 deletion variant had significantly higher PAH-DNA adduct levels compared to those with a functional GSTM1.
• Occupational PAH exposure combined with the GSTM1 deletion showed a trend towards increased adducts, though not statistically significant within the null group.
• This study is the first to demonstrate the influence of a common PAH-metabolizing gene polymorphism on sperm DNA adducts.

Conclusions:

• The GSTM1 genotype significantly influences PAH-DNA adduct levels in human sperm.
• Men with the GSTM1 deletion may be more susceptible to DNA damage from PAHs, potentially impacting reproductive health.
• These findings highlight the importance of genetic factors in assessing individual risk from environmental carcinogens.